BRIACELL THERAPEUTICS CORP

Historical 13F Holders

Symbol
BCTX
CUSIP
107930208
All holders as of
Q3 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 107930208 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G/A Amendment 4
8.3% 8/15/2025
Event 6/30/2025
Iroquois Capital Management, LLC 13G
9.1% 7/28/2025
Event 7/15/2025
CVI Investments, Inc. 13G
5.7% 7/22/2025
Event 7/15/2025
CVI Investments, Inc. 13G/A Amendment 1
4.9% 7/21/2025
Event 6/30/2025
3i, LP 13G/A Amendment 1
4.9% 5/13/2025
Event 3/31/2025
CVI Investments, Inc. 13G
8.6% 5/1/2025
Event 4/24/2025
3i, LP 13G
9.9% 2/10/2025
Event 2/5/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 1 66.0 $48.00
2025 Q2 18 63.0 k $184 k
2025 Q1 15 26.0 k $94.1 k